Imricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High

MT Newswires Live

01/29

Imricor Medical Systems (ASX:IMR) said that the US Food and Drug Administration (FDA) has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.

The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging (MRI) labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.

The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2607724972"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607724972\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607724972?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 08:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607724972","market":"fut","top_or_hot":-1,"title":"Imricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) said that the US Food and Drug Administration (FDA) has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.</p><p>The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging (MRI) labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.</p><p>The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-01-29 08:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) said that the US Food and Drug Administration (FDA) has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.</p><p>The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging (MRI) labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.</p><p>The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMR.AU","symbol_name":"IMRICOR MEDICAL SYSTEMS-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2607724972","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607724972","pubTimestamp":1769645613,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  said that the US Food and Drug Administration  has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging  labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI","BK7007":"医疗保健设备","BK7508":"医药生物股","BK7503":"科技股"},"translate_title":"Imricor获得美国FDA对NorthStar测绘系统的许可；股价创五年新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":1},"content_text":"Imricor Medical Systems (ASX:IMR) said that the US Food and Drug Administration (FDA) has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging (MRI) labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}